Saliva

Mammogen and Brilliantly Combine Forces to Advance Community Efforts for Breast Cancer Previvors and Survivors

Thursday, October 14, 2021 - 6:35pm

Brilliantly and Mammogen, Inc., two female-led womens health companies centered around breakthrough technologies designed to solve unmet clinical needs associated with breast cancer, announce a comprehensive partnership expected to improve quality of care for the breast cancer community, both inside and outside of the physicians office.

Key Points: 
  • Brilliantly and Mammogen, Inc., two female-led womens health companies centered around breakthrough technologies designed to solve unmet clinical needs associated with breast cancer, announce a comprehensive partnership expected to improve quality of care for the breast cancer community, both inside and outside of the physicians office.
  • The companys flagship genTRU-breastTM program leverages novel messenger RNA (mRNA) technology to non-invasively detect and diagnose breast cancer.
  • Brilliantly helps women with the transition from confronting breast cancer to embracing life through innovative products, thoughtful content, and relevant services.
  • The company has recently released their flagship technology, Brilliantly Warm, the first-ever wearable designed specifically for women who have had breast reconstruction surgery.

Imec signs licensing agreement with miDiagnostics to commercialize its patented technology for fast and reliable COVID-19 diagnosis based on exhaled breath

Thursday, October 14, 2021 - 4:39pm

"I note with great pride that we have run an impressive course in the past months," says Luc Van den hove, CEO at imec.

Key Points: 
  • "I note with great pride that we have run an impressive course in the past months," says Luc Van den hove, CEO at imec.
  • "We have succeeded in transforming a promising concept and groundbreaking technology into a functional proof-of-concept that has passed both user tests and clinical studies.
  • This is the first time that we have gone this far in the development of our chip technology towards commercialization.
  • The license agreement with miDiagnostics is an important milestone for imec: Our breakthrough technology will help curb the COVID-19 pandemic in the foreseeable future."

Global Oncology Molecular Diagnostics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Thursday, October 14, 2021 - 2:19pm

Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer.

Key Points: 
  • Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer.
  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?

GBS Inc. Announces its Pre-Submission package is with the FDA

Wednesday, October 13, 2021 - 1:30pm

The purpose of this pre-submission is to confirm with the FDA that GBS is following the proper steps to conduct the clinical studies enabling it to develop the glucose biosensor according to the FDA regulatory standards.

Key Points: 
  • The purpose of this pre-submission is to confirm with the FDA that GBS is following the proper steps to conduct the clinical studies enabling it to develop the glucose biosensor according to the FDA regulatory standards.
  • The pre-submission package will allow the FDA to review the Companys clinical trial plans and protocols while also providing a forum for feedback on these clinical studies as it pursues regulatory approval.
  • GBS is developing a Saliva based Glucose test on the Biosensor Platform to be used in the point-of-care setting.
  • With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help people living with diabetes.

ProPhase Labs Provides Business Update

Wednesday, October 13, 2021 - 1:30pm

We are also building a sizable customer base of independent pharmacies that we anticipate will provide consistent and growing testing revenues for our diagnostics business.

Key Points: 
  • We are also building a sizable customer base of independent pharmacies that we anticipate will provide consistent and growing testing revenues for our diagnostics business.
  • In addition, the integration of recently-acquired Nebula Genomics into our ProPhase Precision Medicine division continues to proceed as planned.
  • ProPhase Labs (Nasdaq: PRPH) (ProPhase) is a diversified biotech and genomics company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics data base to be used for further research.
  • ProPhase Labs has decades of experience researching, developing, manufacturing, distributing, marketing, and selling OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements brand.

Chocolate Isn't the Only Scary Thing Threatening Your Pet This Halloween

Wednesday, October 13, 2021 - 3:05pm

When Stats returned home from work, she found the empty bag and several areas where Charlotte had vomited with significant chocolate evidence.

Key Points: 
  • When Stats returned home from work, she found the empty bag and several areas where Charlotte had vomited with significant chocolate evidence.
  • In the process of treating her for chocolate poisoning, they were able to determine that Charlotte had been suffering from exocrine pancreatic insufficiency (EPI)."
  • "This is an extremely toxic and potentially fatal dose of chocolate," said Dr. Ahna Brutlag, a board-certified veterinary toxicologist at Pet Poison Helpline.
  • In addition to chocolate, pet lovers should keep any candy sweetened with xylitol away from their animals.

The PharmaKon Brings New Access, Diversity to Clinical Trials Through its Allied Approach to Meeting Patients Where They Are

Wednesday, October 6, 2021 - 6:47pm

Three nursing specialties are being used by The PharmaKon to staff its clinical trials: virtual nurses, remote mobile nurses, and patient concierges.

Key Points: 
  • Three nursing specialties are being used by The PharmaKon to staff its clinical trials: virtual nurses, remote mobile nurses, and patient concierges.
  • Over the last two decades few changes have been made to ensure inclusion and diversity in clinical trials, adds Curtis Wilson, VP Clinical Operations at The PharmaKon.
  • Clinical trials are now available to patients who otherwise would not be able to participate in studies.
  • Rural and marginalized communities, LGBTQ, people of color and low-income patients now have an equal opportunity to take part in innovative clinical trials.

ProPhase Labs to Present at the LD Micro Main Event Conference

Wednesday, October 6, 2021 - 1:30pm

GARDEN CITY, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting virtually at the 14th Annual LD Micro Main Event Conference.

Key Points: 
  • GARDEN CITY, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting virtually at the 14th Annual LD Micro Main Event Conference.
  • ProPhase Precision Medicine, Inc., focuses on genomics testing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in DNA.
  • ProPhase Diagnostics offers a broad array of clinical diagnostic and testing services at its CLIA certified laboratories.
  • ProPhase Labs has decades of experience researching, developing, manufacturing, distributing, marketing, and selling OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements brand.

12th Annual Cade Prize Winners Announced

Tuesday, October 5, 2021 - 5:02pm

Judging took place prior to the Cade Prize Awards Ceremony at the Cade Museum on September 30.

Key Points: 
  • Judging took place prior to the Cade Prize Awards Ceremony at the Cade Museum on September 30.
  • The five Cade Prize winners were chosen from a field of 21 Fibonacci Finalists and will share $64,000 in cash prizes.
  • Since 2010, the Cade Prize for Innovation has drawn innovators from research universities and the private sector with groundbreaking, early-stage inventions that have significant market potential.
  • The Cade Prize is one of the museum's capstone initiatives.

Inland Detox Introduces Pharmacogenetics Testing

Tuesday, October 5, 2021 - 1:38pm

Over the last 7 years, the team at Inland Detox has helped people recover from addiction.

Key Points: 
  • Over the last 7 years, the team at Inland Detox has helped people recover from addiction.
  • Recently, we took another step in helping our clients by introducing pharmacogenetic testing into our services.
  • Inland Detox has the most up-to-date, comprehensive pharmacogenetic testing to help our clients get sober with fewer withdrawal symptoms.
  • If you're looking for detox or rehab near Riverside County / Inland Empire area, contact us today.